Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/26/2005WO2005047461A2 Polypeptide display libraries and methods of making and using thereof
05/26/2005WO2005047458A2 Modified recombinant vaccina viruses and other microorganisms, uses thereof
05/26/2005WO2005047455A2 Methods for the production of apolipoproteins in transgenic plants
05/26/2005WO2005047338A1 Cancer cell targeting gene delivery method
05/26/2005WO2005047337A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
05/26/2005WO2005047336A1 Protein complex using immunoglobulin fragment andmethod for the preparation thereof
05/26/2005WO2005047335A1 Method for themass production of immunoglobulin constant region
05/26/2005WO2005047334A1 Igg fc fragment for a drug carrier and method for the preparation thereof
05/26/2005WO2005047333A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof
05/26/2005WO2005047329A1 An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
05/26/2005WO2005047321A2 Polynucleotides for inhibition of polypeptide expression and methods of use
05/26/2005WO2005047317A1 Avidin mutants
05/26/2005WO2005047315A2 Optimized expression of hpv 58 l1 in yeast
05/26/2005WO2005047314A2 Fgf-beta binding and supported peptides
05/26/2005WO2005047302A1 Expression in filamentous fungi of protease inhibitors and variants thereof
05/26/2005WO2005047301A1 Improvements in or relating to polynucleotide arrays
05/26/2005WO2005047300A2 Improved methods and compositions for rna interference
05/26/2005WO2005046732A2 Methods and compositions for the inhibition of hiv-1 replication
05/26/2005WO2005046731A1 Interference with c-maf function in multiple myeloma
05/26/2005WO2005046710A2 Tgf-beta binding and supported peptides
05/26/2005WO2005046709A2 Tgf - beta binding and supported peptides
05/26/2005WO2005046704A1 Pharmaceutical product comprising tissue of the male vegetal reproductive system
05/26/2005WO2005046622A2 Custom vectors for treating and preventing pancreatic cancer
05/26/2005WO2005046616A2 Viral propagation system and uses thereof
05/26/2005WO2005046614A2 System for treating and preventing breast cancer
05/26/2005WO2005046585A2 Vps35-based assays and methods for treating alzheimer’s disease
05/26/2005WO2005046579A2 Defined dose therapeutic phage
05/26/2005WO2005046572A2 Targeted delivery of controlled release polymer systems
05/26/2005WO2005046565A2 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases
05/26/2005WO2005046564A2 Diagnosis and treatment of liver fibrosis
05/26/2005WO2005046452A2 A polypeptide complex that regulates cell cycle and anergy
05/26/2005WO2005046450A2 Method for diagnosis and treatment of pulmonary disorders
05/26/2005WO2005046314A2 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes
05/26/2005WO2005028642A3 Method of culturing cells including the inhibition of the expression of a gene or genes involved in cell cycle control
05/26/2005WO2005026316A3 Alphavirus vaccines
05/26/2005WO2005025624A3 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases
05/26/2005WO2005018537A3 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
05/26/2005WO2005012516A3 Maize cellulose synthases and uses thereof
05/26/2005WO2005012336A3 Uranium-chelating peptides and uses thereof
05/26/2005WO2004113570A3 Genotype test for dogs
05/26/2005WO2004096826A3 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna)
05/26/2005WO2004092356A3 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules
05/26/2005WO2004087924A3 Method for delivery of substances to intracellular microorganisms
05/26/2005WO2004085620A3 Novel attached cell lines
05/26/2005WO2004073604A3 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
05/26/2005WO2004070016A3 System for expression of genes in plants
05/26/2005WO2004070008A3 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
05/26/2005WO2004063341A3 Hematopoietic stem cell niche cells
05/26/2005WO2004056984A3 Enzymatic method for the isolation of dna from plant tissue
05/26/2005WO2004056312A3 Immunoglobulin variants and uses thereof
05/26/2005WO2004056179A3 Genes conferring herbicide resistance
05/26/2005WO2004053088A3 Genetic computing using combinatorial transcription control
05/26/2005WO2004046326A3 Modulation of interleukin 22 receptor expression
05/26/2005WO2004044217A3 Dna sequences from tcd genomic region of photorhabdus luminescens
05/26/2005WO2004044208A3 Food flours with specific technological characteristics and low allergenicity
05/26/2005WO2004029747A3 Method for producing virtual chromosomes
05/26/2005WO2004027028A3 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
05/26/2005WO2003053341A3 Antisense modulation of ship-1 expression
05/26/2005US20050114927 Virus-resistant transgenic plants expressing L3
05/26/2005US20050114926 Method of increasing the transgene-coded biomolecule content in organisms
05/26/2005US20050114925 Potatoes having an increased yield of starch per plant body and method for producing the same
05/26/2005US20050114924 Down-regulation and silencing of allergen genes in transgenic peanut plants
05/26/2005US20050114923 transgenic plants genetically engineered to exhibit a change in color phenotype under the control of promoter elements that are selectively responsive to the presence of a particular contaminant in the environment
05/26/2005US20050114921 For producing green note compounds comprising reacting fatty acid hydroperoxide in the presence of isolated recombinant protein
05/26/2005US20050114920 for producing polypeptides in cells of host plants comprising genetically transformed cells of the host plant having integrated in their nuclear genome, an inactive or silenced foreign nucleic acid sequence, which is capable of encoding, upon its activation, the polypeptides
05/26/2005US20050114918 System and method of embryo delivery for manufactured seeds
05/26/2005US20050114916 Production of proteins in eggs
05/26/2005US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
05/26/2005US20050114913 Methods and compositions for generating homozygous mutations
05/26/2005US20050114912 Model for neurodegenerative disorders
05/26/2005US20050114910 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
05/26/2005US20050114040 Information processing system using nucleotide sequence-related information
05/26/2005US20050113568 Microarrays; animal husbandry; derived from Kagoshima Berkshire
05/26/2005US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization
05/26/2005US20050113326 Gene expression inhibition; connective tissue growth factor modulators; nucleosides, phosphorothioate/phosphodiester linkages; metabolic diseases, diabetes
05/26/2005US20050113325 Linked/conjugated to lipid, fatty acid, and/or sterol; for inhibiting cancer cell proliferation
05/26/2005US20050113324 For treatment/prevention of cancer; retrotransposons; enzyme inhibitors/antagonists (antisense agents, nucleoside analog 3'-azido-2',3'-dideoxythymidine) block lengthening of telomeres in telomerase negative cells; gene expression inhibition; host cells; kits
05/26/2005US20050113323 Introducing antisense nucleotides which are complementary to untranslated region of prostate tumor inducing gene
05/26/2005US20050113322 Oligonucleotides which hybridize to inhibit expression; nucleosides; chimera; colloids; cardiovascular disorders; nervous system disorders; diabetes; ischemia/reperfusion injuries
05/26/2005US20050113304 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
05/26/2005US20050113303 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity
05/26/2005US20050113296 Methods for identifying antimicrobial agents, the agents identified therewith and methods of using same
05/26/2005US20050113291 Use of a substance which binds to and initiates signaling of the human SARP-1 receptor or a substance which stimulates release or potentiates the activity of endogenous SARP-1 for the manufacture of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis
05/26/2005US20050113284 Drug for regenerating tissue and vessel and method therefor
05/26/2005US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease
05/26/2005US20050112784 Analyte assay using particulate labels
05/26/2005US20050112765 Genetic engineering polypeptides containing capsids; cell transduction
05/26/2005US20050112764 Sleeping beauty, a transposon vector with a broad host range for the genetic transformation in vertebrates
05/26/2005US20050112763 Control forming within genome of cells, histone protein; induce methylation
05/26/2005US20050112757 Screening using ultraviolet radiation cured adhesives; applying adhesive to cavities in substrate; adjusting wafer; fixing
05/26/2005US20050112755 Ultrafiltration charging membrane
05/26/2005US20050112754 Apparatus and method for amplifying a polynucleotide
05/26/2005US20050112753 Using a multistage plastic filter in common housing
05/26/2005US20050112752 Method for the purification of alphavirus replicon particles
05/26/2005US20050112751 Novel class of therapeutic protein based molecules
05/26/2005US20050112744 Glucose dehydrogenase fusion proteins and their use in expression systems
05/26/2005US20050112737 Aerobic culture product with high concentration of lactic acid; acidity pH; by-product inhibition
05/26/2005US20050112732 Alleles of the glucokinase gene coryneform bacteria
05/26/2005US20050112731 Mutant serine acetyltransferase
05/26/2005US20050112730 Nucleotide sequences which code for the opcA gene
1 ... 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 ... 4023